Company Legal Name
Latest Valuation
Founded Year
Headquarter
Viz.ai, Inc. develops AI-powered software solutions that detect and coordinate care for acute medical conditions, enabling healthcare providers to rapidly identify time-sensitive cases like strokes and pulmonary embolisms. Founded in 2016 and headquartered in San Francisco, the company has established itself as a leading player in the medical AI space by integrating advanced computer vision and machine learning technologies with clinical workflows. The company achieved unicorn status with a $1.2 billion valuation, reflecting strong investor confidence in its proven ability to improve patient outcomes and reduce healthcare costs through automated diagnostic assistance and care coordination platforms.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





